Cortexyme Inc (CRTX) stock is lower by 6.77% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With CRTX Stock Today?
Cortexyme Inc (CRTX) stock is lower by -6.43% while the S&P 500 is higher by 0.3% as of 2:42 PM on Friday, Apr 9. CRTX is down -$2.31 from the previous closing price of $35.90 on volume of 190,866 shares. Over the past year the S&P 500 is higher by 49.44% while CRTX is down -17.16%. CRTX lost -$2.63 per share in the over the last 12 months.
To see InvestorsObserver's Sentiment Score for Cortexyme Inc click here.
More About Cortexyme Inc
Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics.
Click Here to get the full Stock Score Report on Cortexyme Inc (CRTX) Stock.
